UniQuest is an Australian leader in university technology transfer, strategically developing and implementing innovative new ways to fast track research developments to the marketplace.

Our Technology Commercialisationⁱ Division (Techcomⁱ) maximises commercial and social returns from research by identifying and managing breakthrough technologies and innovations with commercial potential. Services are tailored to the needs and demands of our partner and their researchers as well as investors and our commercialisation partners.

We have an extensive intellectual property portfolio based on innovations developed at The University of Queensland and our partner research institutions. 

With1,500+ patents and over 60 start-upscompanies, group revenues have exceeded $320 million in the past five years. Since 2000 UniQuest and its start-ups have raised more than $400 million to take university technologies to market. Sales of products using UQ technology and licensed by UniQuest are running at $3 billion.

Internationally renowned innovations associated with UniQuest include:

• Cervical cancer vaccine Gardasil®
• Drug development company QRx Pharma Ltd
• Medical imaging technology company Magnetica Ltd
• Bioimpedence device company ImpediMed Ltd
• Triple P Positive Parenting Program
• Drought-resistant plant marketer Aussie Colours Pty Ltd
• Text analytics company Leximancer Pty Ltd
• Image search software company Imprezzeo Pty Ltd